Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 20.07.2026 9 Alzheimers Dement 1 BMC Neurol 1 BMJ 1 Brain 1 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 2 Exp Neurol 4 J Alzheimers Dis 1 J Neurochem 6 JAMA 1 Nat Med 1 Nature 1 Neurochem Res 4 Neurology 3 Neuroscience 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. COUCH E, Gantenberg JR, Belanger E
   Adoption of Alzheimer's disease biomarkers by primary care clinicians: findings from the National Dementia Workforce Study.
   Alzheimers Dement. 2026;22:e71665.
   PubMed         Abstract available
   
   
2. THANOU E, Ganz A, Pita-Illobre D, Koopmans F, et al
   Proteomics of post mortem brains in early- and late-onset Alzheimer's disease: Unraveling differential Abeta effects and potential AD biomarkers.
   Alzheimers Dement. 2026;22:e71662.
   PubMed         Abstract available
   
   
3. HICKEN MT, DeAngelis R, Rigby D, Burnside L, et al
   The social environment and cognitive aging over the life course: laying out critical concepts and research gaps.
   Alzheimers Dement. 2026;22:e71648.
   PubMed         Abstract available
   
   
4. ZHANG F, Petersen M, Mapstone M, Hall J, et al
   Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS.
   Alzheimers Dement. 2026;22:e71659.
   PubMed         Abstract available
   
   
5. 
   Correction to "Systemic piezo1 activation improves cerebrovascular function in Alzheimer's disease".
   Alzheimers Dement. 2026;22:e71677.
   PubMed        
   
   
6. HANSEN N, Sadlonova M, Esselmann H, Celano CM, et al
   Early Alzheimer s disease blood biomarkers are associated with a higher risk for postoperative long-term cognitive decline: Insights from the FINDERI study.
   Alzheimers Dement. 2026;22:e71631.
   PubMed         Abstract available
   
   
7. SHAIKH M, Fletcher P, Zaman S, Brown S, et al
   Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome.
   Alzheimers Dement. 2026;22:e71671.
   PubMed         Abstract available
   
   
8. KENNEDY JT, Wisch JK, Handen BL, Hartley S, et al
   Age predicts Alzheimer's in Down syndrome better than MRI, plasma, or cognition.
   Alzheimers Dement. 2026;22:e71661.
   PubMed         Abstract available
   
   
9. AHMADI B, Armstrong M, Asken BM, Reisi-Gahrooei M, et al
   Deep learning-based MRI analysis reveals Lewy body co-pathology accelerates brain aging in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71593.
   PubMed         Abstract available
   
   

   
   BMC Neurol

10. TANG L, Wu N, Zhu Y, Xu H, et al
    Bioinformatic analysis of differentially expressed mitochondrion-related genes, immune cell infiltration, and diagnostic value in Alzheimer's disease.
    BMC Neurol. 2026 Jul 11. doi: 10.1186/s12883-026-05144.
    PubMed         Abstract available
    
    

    
    BMJ

11. BARANIUK C
    Alzheimer's drug lecanemab: FDA approves easier initial use, with "huge implications" for UK.
    BMJ. 2026;394:e100318.
    PubMed        
    
    

    
    Brain

12. MARSDEN M, McLaren JE, Bevan RJ, Penn-Ripley D, et al
    Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.
    Brain. 2026 Jul 13:awag043. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

13. HUANG CX, Pan Y, Xiao H, Wang JH, et al
    Cerebral Glucose Hypometabolism in Alzheimer's Disease: A Meta-Analysis and Transcriptomic-Neuroimaging Study.
    Curr Alzheimer Res. 2026 Jul 8. doi: 10.2174/0115672050470646260624045159.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

14. KANG C, Lee SW, Jung H, Bae Y, et al
    Incidence and Risk of Stroke following Dementia: A Nationwide Cohort Study in South Korea.
    Dement Geriatr Cogn Disord. 2026;55:303-313.
    PubMed         Abstract available
    
    

    
    Exp Neurol

15. TAEI AA, Karimani F, Kaveh N, Khodabakhsh P, et al
    Forty-hertz auditory stimulation restored hippocampal-prefrontal synchrony and attenuated hippocampal hyperexcitability in an STZ-induced Alzheimer's model.
    Exp Neurol. 2026 Jul 15:115931. doi: 10.1016/j.expneurol.2026.115931.
    PubMed         Abstract available
    
    
16. SHIROTANI K, Hatta D, Watanabe K, Saito T, et al
    Trem2 R47H mutation shows mild, but functionally divergent alterations in microglial phenotypes compared to Trem2 deficiency in aged App(NL-F) knock-in mice.
    Exp Neurol. 2026;404:115894.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. MARINELLI L, Puce L, Diotti D, Curra A, et al
    Clinical dissociation and electromyographic convergence of paratonia in cognitive impairment including Alzheimer's disease: Evidence for a shared central inhibitory mechanism.
    J Alzheimers Dis. 2026 Jul 17:13872877261468799. doi: 10.1177/13872877261468799.
    PubMed         Abstract available
    
    
18. MATTKE S, Chen J, Hanson M, Johnson KG, et al
    Projected effect of a high performing blood test on wait times for determination of Alzheimer's disease pathology in the United States.
    J Alzheimers Dis. 2026 Jul 16:13872877261467345. doi: 10.1177/13872877261467345.
    PubMed         Abstract available
    
    
19. DOGANYIGIT B, Schurr T, Hofer A, Schutz S, et al
    Multidomain cognitive impairment, along with comorbidities and psychiatric hospitalizations, shorten survival time of patients with Alzheimer's disease dementia: A long term, naturalistic follow-up study.
    J Alzheimers Dis. 2026 Jul 11:13872877261468789. doi: 10.1177/13872877261468789.
    PubMed         Abstract available
    
    
20. MENG G, Cai L, Mo Z, An S, et al
    Mitophagy deficiency and calcium dyshomeostasis underlying the pathogenesis and progression of Alzheimer's disease.
    J Alzheimers Dis. 2026 Jul 11:13872877261465779. doi: 10.1177/13872877261465779.
    PubMed         Abstract available
    
    

    
    J Neurochem

21. AKTAS E, Yurt I, Cerlet YN, Hanagasi HA, et al
    Rethinking Alzheimer's Disease Therapy: From Amyloid-Centric Approaches to Multi-Target Phytochemical Strategies.
    J Neurochem. 2026;170:e70506.
    PubMed         Abstract available
    
    

    
    JAMA

22. SCHINDLER SE, Wolk DA
    Predicting Risk of Cognitive Impairment With Alzheimer Disease Blood Biomarkers.
    JAMA. 2026 Jul 14. doi: 10.1001/jama.2026.13322.
    PubMed        
    
    
23. RABINOVICI GD, Grill JD
    Ceperognastat in Alzheimer Disease: Lessons From a Negative Clinical Trial.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.12323.
    PubMed        
    
    
24. FLEISHER AS, Munsie L, Mancini M, Cheng YJ, et al
    Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial.
    JAMA. 2026 Jul 13:e2612768. doi: 10.1001/jama.2026.12768.
    PubMed         Abstract available
    
    
25. BLAZHENETS G, Soleimani-Meigooni DN, Chiotis K, Allen IE, et al
    Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
    JAMA. 2026 Jul 13:e2613116. doi: 10.1001/jama.2026.13116.
    PubMed         Abstract available
    
    
26. BROWN CA, Robinson JL, Das SR, McGrew E, et al
    Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.
    JAMA. 2026 Jul 12:e2613058. doi: 10.1001/jama.2026.13058.
    PubMed         Abstract available
    
    
27. 
    Ceperognastat in Early Symptomatic Alzheimer Disease: Research Summary.
    JAMA. 2026 Jul 13:e2612911. doi: 10.1001/jama.2026.12911.
    PubMed        
    
    

    
    Nat Med

28. CROESE T, Mummery CJ, Bregman N, Bracha D, et al
    Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.
    Nat Med. 2026 Jul 15. doi: 10.1038/s41591-026-04547.
    PubMed         Abstract available
    
    

    
    Nature

29. LUQUEZ T, Algoo J, Chiu R, Mares JA, et al
    Cell-type signatures of Alzheimer's disease shared across population groups.
    Nature. 2026 Jul 15. doi: 10.1038/s41586-026-10793.
    PubMed         Abstract available
    
    

    
    Neurochem Res

30. MOHAMADPOUR M, Amandadi M, Javan M, Hosseinkhani S, et al
    A Combination of Artemisinin, N-acetylcysteine, Resveratrol, and Hesperidin Ameliorates Hippocampal Damage and Pathological Features in an Experimental Model of Alzheimer's Disease.
    Neurochem Res. 2026;51:215.
    PubMed         Abstract available
    
    

    
    Neurology

31. GRILL JD, Graff-Radford J
    The Promise and Peril of Alzheimer Disease Prevention.
    Neurology. 2026;107:e218348.
    PubMed         Abstract available
    
    
32. PAEZ A, Pinol-Ripoll G, Carnes-Vendrell A, Dakterzada F, et al
    Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.
    Neurology. 2026;107:e218307.
    PubMed         Abstract available
    
    
33. COYSH T, Laban R, Veleva E, Heslegrave AJ, et al
    Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.
    Neurology. 2026;107:e214712.
    PubMed         Abstract available
    
    
34. BELLOMO G, Gaetani L
    Plasma P-Tau217: A Powerful Alzheimer Disease Biomarker in the Right Clinical Context.
    Neurology. 2026;107:e214821.
    PubMed        
    
    

    
    Neuroscience

35. ASMABI V, Anoop V
    Multimodal neuroimaging-based deep learning framework for pattern analysis and early prediction of neurodegenerative diseases.
    Neuroscience. 2026;610:36-48.
    PubMed         Abstract available
    
    
36. UDDIN KN, Ghose P, Njie E, Mahmood N, et al
    Machine Learning and Deep Learning for Neurological Disease Analysis: A Systematic Review Across Five Major Disorders.
    Neuroscience. 2026;610:55-90.
    PubMed         Abstract available
    
    
37. HAN J, Wu S, Cui X, Zhou X, et al
    CAPNS1 restoration partially alleviates mitochondrial dysfunction and synaptic deficits in Alzheimer's disease through the Ca(2+)-CaMKIIbeta-MAPK-PGC-1alpha axis.
    Neuroscience. 2026;611:432-449.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. WONG DYK, Fu WY, Uhm H, Jiang Y, et al
    Repurposing trazodone for Alzheimer's disease to modulate soluble ST2 levels and alleviate Alzheimer's pathology.
    Proc Natl Acad Sci U S A. 2026;123:e2536489123.
    PubMed         Abstract available
    
    
39. KHURSHEED A, Shang Q, Zhang H, Tian Y, et al
    3D nanoscale imaging of amyloid-beta oligomer interactions with extracellular vesicles by cryo-ET.
    Proc Natl Acad Sci U S A. 2026;123:e2610068123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum